The most recent trading session ended with CVS Health (CVS) standing at $54.55, reflecting a +1.36% shift from the previouse trading day's closing. The stock's performance was ahead of the S&P 500's ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

European issuers initially struggled to adapt to the higher cost of funding after a decade of zero to negative interest rates ...

Store closures in the U.S. last year hit the highest level since the pandemic — and even more locations are expected to shutter this year, as shoppers’ dollars increasingly go to a few industry ...

Jimmy Butler was suspended by the Miami Heat for the second time in three weeks, a move that adds to the possibility he ...

Abby Jones’ first stop of the day delivering medication was the home of 90-year-old Sarah Campbell Kier. “Come in!” yelled ...

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...